Rare diseases
Investigational molecules
Locations
Study of Durbactagene Autoleucel and Drug Combination for Adults with Relapsed and Refractory Multiple Myeloma
GermanyStudy of Ifinatamab Deruxtecan for Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer
GermanyStudy of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment
GermanyStudy on the Effects of Subcutaneous Human Immunoglobulin (Newnorm) for Patients with Primary Immunodeficiency Diseases
GermanyStudy on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery
GermanyStudy on Dostarlimab, Carboplatin, and Paclitaxel for Patients with Recurrent or Advanced Endometrial Cancer
GermanyStudy on the Safety and Effects of ICT01, Aldesleukin, and Pembrolizumab for Patients with Advanced Solid Tumors
GermanyStudy on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin
GermanyStudy on the Safety and Tolerability of ST-920 Gene Therapy for Patients with Fabry Disease
GermanyStudy of Lutetium (177Lu) Edotreotide compared to standard treatment in patients with aggressive Grade 2 and Grade 3 gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
GermanyStudy on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp
GermanyStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
